
The aim of our study was to evaluate the efficacy of a zzso zzso plus zzso to control zzso in patients zzso receiving zzso Moreover, we evaluated the amount of their food intake zzso in the week following therapy, in order to measure any reduction of calories consumption related to zzso zzso and vomiting zzso 

Patients affected with advanced cancer were treated with zzso 250 zzso plus zzso 20 zzso before zzso zzso zzso and zzso were monitored by a zzso zzso Complete Response zzso no vomiting and no rescue zzso was the primary zzso Complete Control zzso zzso and no more than mild zzso and the evaluation of zzso were the secondary zzso The zzso were evaluated during the acute zzso zzso the delayed zzso zzso and overall zzso zzso zzso 

Thirty-five patients were zzso zzso and zzso of patients achieved zzso and zzso respectively, during the acute zzso zzso and zzso of patients achieved zzso and zzso during the delayed zzso zzso and zzso of patients achieved zzso and zzso during the overall zzso During the acute phase, patients with a zzso without zzso had a median daily zzso of zzso zzso whereas patients with zzso and presence of mild zzso had a median daily zzso of zzso zzso zzso zzso p zzso zzso 

Our preliminary results confirm the efficacy of a zzso zzso plus zzso to prevent both acute and delayed zzso and zzso Moreover, the efficacy of zzso in zzso and vomiting control seems to warrant adequate caloric intake in these zzso 

